Literature DB >> 2642440

Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.

M Podda1, M Zuin, P M Battezzati, C Ghezzi, C de Fazio, M L Dioguardi.   

Abstract

Chenodeoxycholic acid (CDC) and ursodeoxycholic acid (UDC) have distinct physicochemical and metabolic properties which, being complementary, should favor more rapid removal of cholesterol from gallstones when both bile acids are administered together. To see if the combination is more effective and well tolerated, we have compared 5 mg/kg of CDC plus 5 mg/kg of UDC with a 10-mg/kg dose of UDC alone in 120 patients with radiolucent, sonographically confirmed gallstones and characteristics favoring complete dissolution. Ursodeoxycholic acid was chosen as the reference because it dissolves stones faster and is better tolerated than CDC. To minimize the influence of stone size, the major determinant of dissolution, patients were divided, on admission, into two groups according to the maximum stone diameter: 50 had stones less than or equal to 5 mm, 70 had stones greater than 5 mm but less than 15 mm. The effects of treatment on stone dissolution evaluated by cholecystography and ultrasonography at 6, 12, and 24 mo, were analyzed by the actuarial life-table method. In the group with smaller stones, significantly more patients had obtained complete dissolution after treatment with the combination (52%) than after treatment with UDC alone (24%) at 6 mo. After longer periods, results were still better with the combination, although the differences from UDC alone became smaller. In the patients with larger stones, rates of complete and partial dissolutions were higher after treatment with the combination (51% vs. 24% with UDC) at 6 mo and again the differences had become smaller after longer treatment. Although not statistically significant, stone calcification occurred more often with UDC (7 cases) than with the combination (1 case). We conclude that CDC plus UDC is preferable to UDC alone because it dissolves stones more quickly, with a lower incidence of stone calcification, and may result in reduced cost of treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642440     DOI: 10.1016/0016-5085(89)90784-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  Gastroenterology.

Authors:  L J O'Donnell; E M Alstead; M J Farthing
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

2.  Cost-effectiveness of ursodiol: the creature from the black box.

Authors:  A K Diehl
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

Review 3.  A watershed in gallstone therapy?

Authors:  R R Schade; D H Van Thiel; R L Wechsler
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

4.  Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.

Authors:  A Hellstern; U Leuschner; A Benjaminov; H Ackermann; T Heine; D Festi; M Orsini; E Roda; T C Northfield; R Jazrawi; W Kurtz; H J Schmeck-Lindenau; J Stumpf; B E Eidsvoll; E Aadland; G Lux; E Boehnke; D Wurbs; M Delhaye; M Cremer; I Sinn; E Höring; U v Gaisberg; M Neubrand; F Paul
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Medical management of gallstones: a cost-effectiveness analysis.

Authors:  M C Weinstein; C M Coley; J M Richter
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

6.  Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.

Authors:  D Burnett; A Ertan; R Jones; J P O'Leary; R Mackie; J E Robinson; G Salen; L Stahlgren; D H Van Thiel; L Vassy
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

Review 7.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

8.  Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.

Authors:  D K Agarwal; G Choudhuri; V A Saraswat; T S Negi; V K Kapoor; R Saxena
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.

Authors:  J W Marks; T Stein; L J Schoenfield
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

10.  Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA. Results, side effects, and correlation with CT imaging.

Authors:  P Janowitz; K A Schumacher; W Swobodnik; W Kratzer; J Tudyka; J G Wechsler
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.